| MMGBSA as a tool to understand the binding affinities of filamin–peptide interactions M Ylilauri, OT Pentikäinen Journal of chemical information and modeling 53 (10), 2626-2633, 2013 | 339 | 2013 |
| Selective binding of collagen subtypes by integrin α1I, α2I, and α10I domains M Tulla, OT Pentikäinen, T Viitasalo, J Käpylä, U Impola, P Nykvist, ... Journal of Biological Chemistry 276 (51), 48206-48212, 2001 | 332 | 2001 |
| BODIL: a molecular modeling environment for structure-function analysis and drug design JV Lehtonen, DJ Still, V Rantanen, J Ekholm, D Björklund, Z Iftikhar, ... Journal of computer-aided molecular design 18 (6), 401-419, 2004 | 253 | 2004 |
| α11β1 integrin recognizes the GFOGER sequence in interstitial collagens WM Zhang, J Käpylä, JS Puranen, CG Knight, CF Tiger, ... Journal of Biological Chemistry 278 (9), 7270-7277, 2003 | 239 | 2003 |
| Structure of three tandem filamin domains reveals auto‐inhibition of ligand binding Y Lad, T Kiema, P Jiang, OT Pentikäinen, CH Coles, ID Campbell, ... The EMBO journal 26 (17), 3993-4004, 2007 | 192 | 2007 |
| A peptide inhibiting the collagen binding function of integrin α2I domain J Ivaska, J Käpylä, O Pentikäinen, AM Hoffrén, J Hermonen, P Huttunen, ... Journal of Biological Chemistry 274 (6), 3513-3521, 1999 | 132 | 1999 |
| Rocker: open source, easy-to-use tool for AUC and enrichment calculations and ROC visualization S Lätti, S Niinivehmas, OT Pentikäinen Journal of cheminformatics 8 (1), 45, 2016 | 115 | 2016 |
| Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes H Raunio, M Kuusisto, RO Juvonen, OT Pentikäinen Frontiers in pharmacology 6, 123, 2015 | 112 | 2015 |
| Integrin α2I domain recognizes type I and type IV collagens by different mechanisms J Käpylä, J Ivaska, R Riikonen, P Nykvist, O Pentikäinen, M Johnson, ... Journal of Biological Chemistry 275 (5), 3348-3354, 2000 | 101 | 2000 |
| Synthesis and pharmacological characterization of N3-substituted willardiine derivatives: role of the substituent at the 5-position of the uracil ring in the development of … NP Dolman, JCA More, A Alt, JL Knauss, OT Pentikäinen, CR Glasser, ... Journal of medicinal chemistry 50 (7), 1558-1570, 2007 | 95 | 2007 |
| Molecular basis of filamin A-FilGAP interaction and its impairment in congenital disorders associated with filamin A mutations F Nakamura, O Heikkinen, OT Pentikäinen, TM Osborn, KE Kasza, ... PLoS One 4 (3), e4928, 2009 | 86 | 2009 |
| A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors S Pathania, OT Pentikäinen, PK Singh Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (2), 188631, 2021 | 84 | 2021 |
| AMPA receptors and bacterial periplasmic amino acid‐binding proteins share the ionic mechanism of ligand recognition M Lampinen, O Pentikäinen, MS Johnson, K Keinänen The EMBO journal, 1998 | 84 | 1998 |
| New inhibitors of 17β-hydroxysteroid dehydrogenase type 1 J Messinger, L Hirvelä, B Husen, L Kangas, P Koskimies, O Pentikäinen, ... Molecular and cellular endocrinology 248 (1-2), 192-198, 2006 | 83 | 2006 |
| Chicken avidin-related proteins show altered biotin-binding and physico-chemical properties as compared with avidin OH Laitinen, VP Hytönen, MK Ahlroth, OT Pentikäinen, C Gallagher, ... Biochemical Journal 363 (3), 609-617, 2002 | 78 | 2002 |
| Case-specific performance of MM-PBSA, MM-GBSA, and SIE in virtual screening SI Virtanen, SP Niinivehmas, OT Pentikäinen Journal of Molecular Graphics and Modelling 62, 303-318, 2015 | 76 | 2015 |
| Vascular amine oxidases are needed for leukocyte extravasation into inflamed joints in vivo F Marttila‐Ichihara, DJ Smith, C Stolen, GG Yegutkin, K Elima, N Mercier, ... Arthritis & Rheumatism 54 (9), 2852-2862, 2006 | 75 | 2006 |
| Construction of hevein (Hev b 6.02) with reduced allergenicity for immunotherapy of latex allergy by comutation of six amino acid residues on the conformational IgE epitopes P Karisola, J Mikkola, N Kalkkinen, KJ Airenne, OH Laitinen, S Repo, ... The Journal of Immunology 172 (4), 2621-2628, 2004 | 72 | 2004 |
| Mammary-derived growth inhibitor (MDGI) interacts with integrin α-subunits and suppresses integrin activity and invasion J Nevo, A Mai, S Tuomi, T Pellinen, OT Pentikäinen, P Heikkilä, J Lundin, ... Oncogene 29 (49), 6452-6463, 2010 | 71 | 2010 |
| Suitability of MMGBSA for the selection of correct ligand binding modes from docking results M Ahinko, S Niinivehmas, E Jokinen, OT Pentikäinen Chemical Biology & Drug Design 93 (4), 522-538, 2019 | 70 | 2019 |
Pekka PostilaUniversity of TurkuVerified email at aurlide.fi
